HealthPatch MD Wins Approval for Japanese Market

vital biometrics and wearable techVital Connect’s HealthPatch MD device has been approved for the Japanese market, the company has announced. Now that it has received Medical Device Ninsho certification, the device can be used by medical professionals in Japan to monitor patients in the hospital and at home.

The HealthPatch MD is a small, thin wearable device that can monitor a number of biometric signals, providing medical professionals with the ability to remotely monitor patients’ respiratory and cardiac data, body movement, temperature, and other such health indicators. The data is transferred via BlueTooth 4.0, and can be interpreted and analyzed using Vital Connect’s custom-designed software.
The device has been gaining a lot of credibility over the past several months. Last fall, GlaxoSmithKline used it in a study to determine the viability of mobile biometrics technology for serious healthcare applications, with excellent results. Vital Connect also struck a partnership with Philips and the Radboud University Nijmegan Medical Center to integrate the HealthPatch MD into a cloud-based healthcare platform – a development that echoed another deal the company struck shortly before that to have its device integrated into LifeWatch AG’s mobile platform.
Given the serious demographic issues that Japan’s healthcare system is starting to grapple with (a third of its population will be over 65 years of age by 2030), Vital Connect’s device will likely prove useful to many of the country’s medical professionals.